What We Do

Supporting a Wide Range of Drug Modalities and Platforms

Drug /Molecule Type

  • Small Molecule NCE
  • Biologics
  • Oligonucleotides
  • Biomarkers
  • Immunogenicity/ADA
  • Neutralizing ADA

Assay/Platform Expertise

  • LC-MS/MS
  • HRMS
  • LBA (ELISA, ECL, RIA, etc.)
  • Molecular (qPCR, RT-qPCR, ddPCR, etc.)
  • Cell-Based (Potency, ELISpot, FACS, etc.)

Stages of Development

  • Discovery
  • IND-Enabling/GLP Preclinical
  • Clinical Phase I – IV
  • BLA/NDA Support
  • Post-Market Approval

Ask How We Can Help You

Our bioanalytical services consulting projects have assisted biopharmaceutical companies and contract research organizations in a variety of ways. Contact us today and let us know what challenges you are facing.